Novel piperidinylpyrimidine derivatives as inhibitors of HIV-1 LTR activation

Add time:07/11/2019    Source:sciencedirect.com

Piperidinylpyrimidine derivatives, previously prepared as inhibitors of TNF-α production, were evaluated for their inhibitory activity against HIV-1 LTR activation. Some of these derivatives inhibited activation of HIV-1 LTR-directed CAT gene expression induced by PMA in Jurkat cells. In this report, we describe SAR in this series of compounds and show that the 3,4-methylenedioxybenzoyl (piperonyloyl) group on the nitrogen of piperidine and lipophilic substitution at the C(6)-position of pyrimidine are important for this inhibitory activity. Some of the synthesized compounds also inhibited HIV-1 LTR transactivation induced by viral protein Tat. These results suggest that piperidinylpyrimidines are useful as potent AIDS therapeutics that directly inhibit HIV-1 LTR activation and indirectly suppress TNF-α production.

We also recommend Trading Suppliers and Manufacturers of (4-piperidin-1-ylpyrimidin-2-yl)methanol (cas 105950-91-2). Pls Click Website Link as below: cas 105950-91-2 suppliers

Prev:Dinuclear Cu(I) complexes prepared from 2-diphenylphosphino-6-methylpyridine
Next:Self-formation of Hierarchical SAPO-11 Molecular Sieves as an Efficient Hydroisomerization Support)